Asterias Biotherapeutics, Inc. - FORM 10-K - EX-23.2 - EXHIBIT 23.2 - March 10, 2015

Attached files

file filename
EX-31 - EXHIBIT 31 - Asterias Biotherapeutics, Inc.ex31.htm
EX-32 - EXHIBIT 32 - Asterias Biotherapeutics, Inc.ex32.htm
EX-23.1 - EXHIBIT 23.1 - Asterias Biotherapeutics, Inc.ex23_1.htm
EX-10.26 - EXHIBIT 10.26 - Asterias Biotherapeutics, Inc.ex10_26.htm
EX-10.25 - EXHIBIT 10.25 - Asterias Biotherapeutics, Inc.ex10_25.htm
EX-10.27 - EXHIBIT 10.27 - Asterias Biotherapeutics, Inc.ex10_27.htm
EXCEL - IDEA: XBRL DOCUMENT - Asterias Biotherapeutics, Inc.Financial_Report.xls
10-K - ASTERIAS BIOTHERAPEUTICS, INC 10-K 12-31-2014 - Asterias Biotherapeutics, Inc.form10k.htm
EXHIBIT 23.2
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement and related Prospectus of Asterias Biotherapeutics, Inc. (the “Company”) on Form S-3 (Registration No. 333-200745) of our report dated March 17, 2014, with respect to the financial statements of the Company for the year ended December 31, 2013 and for the period from September 24, 2012 (inception) to December 31, 2012, included in its Annual Report (Form 10-K) for the year ended December 31, 2014, filed with the U.S. Securities and Exchange Commission.

/s/ Rothstein Kass
  
   
New York, New York
  
March 6, 2015
  

 

Asterias Biotherapeutics, Inc. Reports

Also read